CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) [Phase 3]
Summary
Phase 3 clinical trial evaluating PDT with Photofrin for unresectable advanced perihilar cholangiocarcinoma has been terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Concordia Laboratories Inc. | Conditions: Hilar Cholangiocarcinoma | Phase 3 | Status: TERMINATED | Results posted: 2019-08-28